Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen after caesarean section in women with hypertensive disorders of pregnancy
ACTRN12624000883516Phase 4Recruiting
- Sponsor
- Royal North Shore Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ibuprofen in maternal hypertension (HDP), hypertension (HTN), pregnancy-induced hypertension (PIH) and 1 more (2 arms), sponsored by Royal North Shore Hospital. Primary endpoint: Development of severe hypertension. Started Aug 2024; status: recruiting.
02
Drugs
ibuprofen
03
Conditions
maternal hypertension (HDP)hypertension (HTN)pregnancy-induced hypertension (PIH)preeclampsia
Beyond the preview
Go deeper on ACTRN12624000883516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000883516.